title: Treatment of osteoporosis with vitamin D.
authors.affiliation: WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK.
authors.forename: J A
authors.initials: JA
authors.lastname: Kanis
authors.forename: E V
authors.initials: EV
authors.lastname: McCloskey
authors.forename: D
authors.initials: D
authors.lastname: de Takats
authors.forename: J
authors.initials: J
authors.lastname: Bernard
authors.forename: D M
authors.initials: DM
authors.lastname: Zhang
mesh_terms: D015519:Bone Density / Q000187:drug effects; D002117:Calcitriol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002762:Cholecalciferol / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004872:Ergocalciferols / Q000627:therapeutic use; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006801:Humans; D006887:Hydroxycholecalciferols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D006934:Hypercalcemia / Q000139:chemically induced; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D016103:Spinal Fractures / Q000517:prevention & control; D014807:Vitamin D / Q000627:therapeutic use*
chemical_list: D004872:Ergocalciferols; D006887:Hydroxycholecalciferols; D014807:Vitamin D; D002762:Cholecalciferol; D002117:Calcitriol; C008088:alfacalcidol